Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities DNLI - Denali Therapeutics Inc.
17.8 M
LAST VALUE
-4.03%
2 YEAR CAGR
-28.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR